Trials / Conditions / Type 2 Diabetic Nephropathy

Type 2 Diabetic Nephropathy

5 registered clinical trials studyying Type 2 Diabetic Nephropathy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Pat NCT06606093	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy NCT06182891	The Affiliated Hospital of Xuzhou Medical University	N/A
Completed	Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan NCT03147677	The Third Xiangya Hospital of Central South University	Phase 4
Terminated	A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy NCT01488877	Pfizer	Phase 1
Unknown	Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in T NCT01300273	Shanghai Jiao Tong University School of Medicine	Phase 4